← Leaderboards
Kan N Hor
Vanderbilt University Medical Center
$315,338
Attributed
$1,576,689
Total exposure
1
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $838.3K · FY2024–25$1M$750K$500K$250K$0
'24
'25
Funding mix
By agency
NIH$1,576,689 · 1
By mechanism
R01$1,576,689 · 1
Top collaborators
- Craig J. Goergen2 shared
- Guang Lin2 shared
- Larry W. Markham2 shared
- Jonathan Harvey Soslow2 shared
Most similar at Vanderbilt University Medical Center
Same institution · by research overlap
- Jonathan Harvey Soslow$5,426,669
- Wei-Qi Wei$9,737,275
- Rita Bottino$733,971
- Karen Marie Winkfield$1,589,531
- Simon Neil Vandekar$2,113,210
Others in their field
Other Rising Stars on “Becker Muscular Dystrophy”
- Ryan David Wuebbles · Strykagen Corporation$1,953,245
- Amy Moore · Research Triangle Institute$415,000
- Haishan Xiong · Panorama Medicine, Inc.$333,843
- Larry W. Markham · Vanderbilt University Medical Center$315,338
- Guang Lin · Vanderbilt University Medical Center$315,338
- Monkol Lek · Myofinity Biosciences Inc$275,651
Research focus
Becker Muscular DystrophyBiological MarkersBiomarker IdentificationBiomedical EngineeringBloodCardiacCardiac Magnetic Resonance ImagingCardiomyopathiesCardiovascular DiseasesCardiovascular SystemCaringCausal ModelCause Of DeathCessation Of LifeChargeClinical CareClinical DataClinical ResearchClinical TrialsCloud BasedCohortCollaborationsCollaborative ApproachCollection
Grant awards (2)
Modeling Mortality in Duchenne Muscular Dystrophy Cardiomyopathy: Identification of Surrogate Outcome Measures for DMD Drug Trials$738,341
R01 · FY2025 · HL
Modeling Mortality in Duchenne Muscular Dystrophy Cardiomyopathy: Identification of Surrogate Outcome Measures for DMD Drug Trials$838,348
R01 · FY2024 · HL